Progress: The Quality Initiative
This week, AHCA announced that skilled nursing center members achieved a greater percent reduction than non-members in the use of antipsychotic drugs from 2011 to 2018, with the AHCA member percent reduction at 37.2 percent and non-members at 34.4 percent.
According to data from the Centers for Medicare & Medicaid Services (CMS), 23.6 percent of residents in member centers received an antipsychotic medication in the fourth quarter of 2011 compared with 14.8 percent of residents in the first quarter of 2018.
In March 2018, AHCA announced new three-year goals that continue to focus on safely reducing off-label antipsychotics as well as reducing hospitalizations, improving customer satisfaction, and improving functional outcomes. These goals align with CMS programs, such as Five-Star and Value-Based Purchasing.
While it still has been less than a year into the 2018-2021 Initiative, trends for short-stay rehospitalization, measured by PointRight Pro30, and long-stay antipsychotics continue to improve based on the latest available data. More than 30 percent of members have achieved the short- or long-stay goal in hospitalizations, and more than 50 percent of members have achieved the short- or long-stay goals for antipsychotics.